Welcome to our dedicated page for Blend Labs SEC filings (Ticker: BLND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Access SEC filings for Blend Labs Inc., providing transparency into the company's financial performance, operational metrics, risk factors, and strategic direction. Blend files regular reports with the Securities and Exchange Commission as a publicly traded company on the New York Stock Exchange.
Key filings include quarterly reports (Form 10-Q) detailing revenue from software platform subscriptions, operating expenses, cash flow, and business segment performance across Blend's Mortgage Suite and Consumer Banking Suite. Annual reports (Form 10-K) provide extensive disclosure about the company's business model, competitive landscape, customer concentration, technology infrastructure, and long-term strategy.
Current reports (Form 8-K) announce material events such as earnings releases, management changes, significant contracts, or corporate actions. Proxy statements (DEF 14A) disclose executive compensation, board composition, and governance matters for shareholder review. Insider transaction reports track stock purchases and sales by company executives and directors.
These filings offer detailed insights into Blend's financial condition, including subscription revenue trends, customer acquisition and retention metrics, research and development investments, sales and marketing efficiency, and overall profitability trajectory. Investors use these documents to assess the company's competitive position within the digital lending software market and its ability to capitalize on the ongoing digitization of financial services.
Form 4 Overview: Blend Labs, Inc. (BLND) filed a Form 4 disclosing that Brian Kneafsey, the company’s Head of Revenue, sold 20,000 shares of Class A common stock on 23 June 2025.
Transaction specifics: The disposition was coded “S” (open-market sale) and executed at a weighted-average price of $3.1657 per share, within a range of $3.12–$3.205. Following the sale, Kneafsey still beneficially owns 806,598 shares, indicating the transaction reduced his direct holdings by roughly 2.5%.
Rule 10b5-1 plan: The insider noted that the trade was carried out under a Rule 10b5-1 trading plan adopted on 14 March 2025. Pre-arranged plans can mitigate concerns about informational advantage because trades are scheduled in advance.
Ownership context: Kneafsey is classified as an Officer – Head of Revenue; no director or 10% ownership status was indicated. The filing is made by a single reporting person, and there are no derivative security transactions reported.
Investor takeaways: While any insider sale can draw attention, the size of this sale is modest relative to the insider’s remaining stake, and its execution under a 10b5-1 plan lessens potential negative signalling. No information about Blend Labs’ operational performance, earnings, or other corporate events is provided in this filing.
Form 144 Notice of Proposed Sale filed by Blend Labs (NYSE: BLND) on June 28, 2025, detailing insider trading activity. The filing indicates a proposed sale of 20,000 shares of common stock with an aggregate market value of $63,315 through Charles Schwab & Co.
Key transaction details:
- Securities were originally acquired on February 17, 2020, through an Exercise and Hold transaction
- Sale represents a small portion of total outstanding shares (254,775,978 shares)
- Planned execution date: June 23, 2025
- Previous insider activity: The seller (Brian Kneafsey) sold 45,000 shares on June 16, 2025, for gross proceeds of $145,268
The seller affirms no knowledge of undisclosed material adverse information regarding Blend Labs' operations. This Form 144 represents a declaration of intent to sell securities acquired through stock options, indicating potential insider sentiment.
Blend Labs, Inc. (BLND) has filed a Form 4 indicating that Head of Revenue Brian Kneafsey executed an insider sale on 16 June 2025. The filing shows a disposition of 45,000 Class A common shares at a weighted-average price of $3.2282 per share. The transaction was carried out under a Rule 10b5-1 trading plan adopted on 14 March 2025, signalling that the sale was pre-scheduled and designed to comply with SEC safe-harbor provisions.
Following the sale, Kneafsey’s direct beneficial ownership stands at 826,598 shares. No derivative security transactions were reported in this filing, and there are no indications of additional sales or purchases on the same date. The filing is signed by attorney-in-fact Winnie Ling on 18 June 2025.
While the transaction reduces the insider’s holdings by roughly 5% of his prior position (exact percentage not provided in the filing), the executive remains a significant shareholder. Investors often watch insider activity for sentiment signals; however, the presence of a 10b5-1 plan and the continued large stake suggest that this sale may be more about portfolio diversification or liquidity than a change in outlook.
FAQ
What is the current stock price of Blend Labs (BLND)?
What is the market cap of Blend Labs (BLND)?
